Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
Zhang L, Su K, Liu Q, Li B, Wang Y, Cheng C, Li Y, Xu C, Chen J, Wu H, Zhu M, Mai X, Cao Y, Peng J, Yue Y, Ding Y, Yu D.
Zhang L, et al. Among authors: mai x.
BMC Cancer. 2023 Nov 9;23(1):1081. doi: 10.1186/s12885-023-11601-y.
BMC Cancer. 2023.
PMID: 37946141
Free PMC article.